| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9393591 | Revista Española de Medicina Nuclear | 2005 | 13 Pages |
Abstract
According to our meta-analysis, FDG-PET has high S and intermediate Sp, with few false negative results. These preliminary findings suggest that FDG-PET may be an effective means of identifying patients with recurrent ovarian cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
G. Ruiz-Hernández, R.C. Delgado-Bolton, C. Fernández-Pérez, L. Lapeña-Gutiérrez, J.L. Carreras-Delgado,